Bristol-Myers Squibb CompanyBMY

Is BMY cheap right now? Every multiple below is scored against its own 10-year range, not a sector average.

$61.39+0.82 (+1.35%)24:00 UTC

NYSEHealthcare

Company snapshot

Market Cap

$126B

Large-cap

+48%

2016 — today

10-Year Price

+21%

2016 — today

52-Week Range

$45.59$68.09

Current $61.39· 70%

Bristol-Myers Squibb researches, develops, and commercializes a global biopharmaceutical portfolio spanning hematology, oncology, cardiovascular health, immunology, fibrotic conditions, neuroscience, and infectious diseases. Key therapies include Revlimid, Eliquis, Opdivo, Pomalyst/Imnovid, Orencia, Sprycel, Yervoy, Abraxane, Reblozyl, Empliciti, Zeposia, Breyanzi, Inrebic, and Onureg. Products are distributed worldwide via wholesalers, pharmacies, hospitals, and clinics. Established in 1887, it is based in New York.

Featured in rankings

S&P500 Most Undervalued Healthcare Stocks Best Healthcare Dividend Stocks Most Undervalued Value Stocks Most Undervalued Dividend Stocks Most Undervalued Growth Stocks Cheapest Large-Cap Stocks

Rankings recomputed after each US market close — see where BMY stands against peers.

Similar companies

Healthcare companies of comparable size to BMY
Company	P/E	Div yield
MDTMedtronic plc	24.6	3.0%
SYKStryker Corporation	33.2	1.1%
MCKMcKesson Corporation	26.2	0.4%
CVSCVS Health Corporation	23.9	2.9%
VRTXVertex Pharmaceuticals Incorporated	31.4	—
HCAHCA Healthcare, Inc.	15.8	0.6%
SNYSanofi	78.6	5.6%
ISRGIntuitive Surgical, Inc.	53.9	—